Trapp Todd A's Form 4 filing
Abiomed Inc (ABMD) · filed Nov 3, 2022
- Accession no.
- 0001415889-22-011061
- Filed
- Nov 3, 2022
- Trade date
- Nov 1, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $378.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Trapp Todd ACIK 0001638242 | Officer (VICE PRESIDENT, CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 1, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −263 | $377.82 | −$99,366.66 | 16,664 | Direct | |
| Nov 1, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −479 | $378.64 | −$181,368.56 | 16,185 | Direct | |
| Nov 1, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −191 | $379.35 | −$72,455.85 | 15,994 | Direct | |
| Nov 1, 2022 | Common Stock, $0.01 par value | SSaleDisposed | −67 | $380.20 | −$25,473.4 | 15,927 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.